Deceleration Capacity Improves Prognostic Accuracy of Relative Increase and Final Coronary Physiology in Patients

Jun Wang1,2,3,4, Chengzhe Liu1,2,3,4, Fuding Guo1,2,3,4

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.

Insights

Deceleration capacity (DC) combined with quantitative flow ratio (QFR) improves risk prediction for non-ST-elevation acute coronary syndrome (NSTE-ACS) patients after percutaneous coronary intervention (PCI). This approach enhances existing clinical models for major adverse cardiac and cerebrovascular events (MACCEs).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Physiology

Background:

  • Both coronary physiology and deceleration capacity (DC) have demonstrated prognostic value in acute coronary syndrome (ACS).
  • Quantitative flow ratio (QFR) assesses coronary physiology, while DC reflects autonomic nervous system function.
  • Non-ST-elevation ACS (NSTE-ACS) is a common presentation requiring risk stratification.

Purpose of the Study:

  • To evaluate the prognostic implication of combining DC with QFR-derived coronary physiology in NSTE-ACS patients.
  • To determine if this combined approach improves risk prediction for major adverse cardiac and cerebrovascular events (MACCEs) post-percutaneous coronary intervention (PCI).
  • To assess the predictive efficacy of relative QFR increase and final QFR alongside DC.

Main Methods:

  • Retrospective cohort study including NSTE-ACS patients who underwent successful PCI with pre- and post-procedural QFR.
  • 24-hour DC (DC 24h) data obtained via Holter monitoring.
  • Multivariate Cox regression and ROC analysis used to determine optimal cutoffs and predictive efficacy for MACCEs.

Main Results:

  • Higher post-PCI QFR, higher relative QFR increase, and higher DC were independent predictors of lower MACCE risk.
  • Incorporating low DC (≤2.42) significantly improved the predictive efficacy of low relative QFR increase (≤23%) and low post-PCI QFR (≤0.88) for MACCEs.
  • 31 out of 240 patients experienced MACCEs during a mean follow-up of 21.3 months.

Conclusions:

  • Combining DC with QFR-derived coronary physiology (relative increase and final) enhances MACCE risk prediction in NSTE-ACS patients post-PCI.
  • This integrated approach offers improved prognostic capability compared to models based solely on clinical variables.
  • The findings suggest a potential role for DC and QFR in refining risk stratification strategies for NSTE-ACS.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
97
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
46
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
54